RFK Jr.'s HHS Advances Plan for COVID-19 Vaccine Injury Table Under CICP, Signaling Shift in Compensation and Transparency

The U.S. Department of Health and Human Services (HHS), under Secretary Robert F. Kennedy Jr., is preparing a proposed rule to establish an injury table for COVID-19 countermeasures in the Countermeasures Injury Compensation Program (CICP). The table would list injuries presumed to be caused by covered countermeasures, such as COVID-19 vaccines, based on compelling, reliable, valid, medical, and scientific evidence, along with associated time periods for onset. This would streamline compensation claims by presuming causation for listed injuries, reducing the need for individualized proof in each case.

The notice, posted on the Office of Information and Regulatory Affairs (OIRA) site under RIN 0906-AB31, indicates the proposed rule is slated for November 2026 publication in the Federal Register, with a public comment period ending in January 2027. The initiative follows Kennedy's termination of the COVID-19 emergency declaration and aligns with statutory requirements under the Public Readiness and Emergency Preparedness (PREP) Act for the HHS Secretary to establish such tables when evidence supports presumed causation.

Currently, the CICP—unlike the Vaccine Injury Compensation Program (VICP) for routine vaccines—lacks a dedicated injury table for most countermeasures, including COVID-19 vaccines. Claims require petitioners to demonstrate direct causation with high evidentiary standards, resulting in low approval rates: of over 10,000 COVID-related petitions, only a small fraction (around 1%) have been compensated as of recent data. An injury table could address this by formalizing recognized injuries, such as myocarditis or anaphylaxis, which are already acknowledged in some contexts, while potentially expanding based on evidence.

Stakeholders have mixed reactions. Advocates for greater transparency, including former Kennedy attorney Aaron Siri, have urged the creation of such a table to fulfill legal mandates and support injured individuals. Critics, including some health groups and experts, warn it could be "weaponized" to include speculative conditions or undermine public confidence if not grounded strictly in science. The proposal reflects broader efforts to restore accountability amid documented erosion of trust in health agencies, as low compensation outcomes and case-by-case adjudication have fueled perceptions of inadequate redress for rare but real adverse events.

This move connects to systemic critiques of emergency countermeasures frameworks, where CICP's structure has historically limited payouts compared to VICP, highlighting tensions between rapid deployment of medical products and long-term liability protections. Official sources emphasize evidence-based criteria, but the final table's scope remains to be determined through the rulemaking process.